Yali Fan Selected Research

ONC206

1/2022	ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer.
1/2021	Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer.
1/2020	ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer In Vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yali Fan Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 01/2020
6	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 08/2019
5	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2020
3	Pneumoconiosis 03/2021 - 01/2020
3	Silicosis 03/2021 - 12/2020
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 12/2020
2	Fibrosis (Cirrhosis) 03/2021 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 02/2021 - 01/2021
2	Lung Neoplasms (Lung Cancer) 02/2021 - 11/2018
2	Asbestosis 01/2021 - 12/2020
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 01/2021
1	Hypertension (High Blood Pressure) 08/2022
1	Vasculitis (Vasculitides) 01/2022
1	Hypothyroidism 01/2022
1	Obesity 02/2021
1	Body Weight (Weight, Body) 02/2021
1	Nervous System Trauma 01/2021
1	Carcinogenesis 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Immediate Hypersensitivity 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 12/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2019
1	Sleep Wake Disorders 11/2016
1	Amnesia (Dissociative Amnesia) 11/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2016

Drug/Important Bio-Agent (IBA)

5	TIC10 compoundIBA 01/2022 - 01/2020
3	ONC206IBA 01/2022 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2020
3	Silicon Dioxide (Silica)FDA LinkGeneric 03/2021 - 01/2020
3	Dopamine Receptors (Dopamine Receptor)IBA 02/2021 - 01/2020
3	Biological ProductsIBA 01/2021 - 08/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2021
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2022
2	LigandsIBA 01/2022 - 01/2021
2	LipidsIBA 02/2021 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 08/2022
1	Triglycerides (Triacylglycerol)IBA 08/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	ipatasertibIBA 01/2022
1	Iodide Peroxidase (Deiodinase)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Arginine (L-Arginine)FDA Link 03/2021
1	Proline (L-Proline)FDA Link 03/2021
1	SphingolipidsIBA 03/2021
1	KynurenineIBA 03/2021
1	Messenger RNA (mRNA)IBA 02/2021
1	Atorvastatin (Lipitor)FDA Link 02/2021
1	Benzo(a)pyreneIBA 02/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	polyacrylamide gelsIBA 01/2021
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2021
1	Air Pollutants (Pollutants, Air)IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	MineralsIBA 01/2021
1	Particulate MatterIBA 01/2021
1	AsbestosIBA 12/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2020
1	telomerase RNA (bTR)IBA 12/2020
1	Fish OilsIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2020
1	ProdrugsIBA 01/2020
1	Coal (Coals)IBA 01/2020
1	cremophor ELIBA 01/2020
1	Bronchodilator Agents (Bronchodilators)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 12/2019
1	Cadherins (E-Cadherin)IBA 08/2019
1	VimentinIBA 08/2019
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 11/2018

Therapy/Procedure

2	Fat-Restricted Diet (Diet, Fat Restricted) 01/2022 - 02/2021
2	Therapeutics 01/2021 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2021
1	Moxibustion 11/2016
1	Aftercare (After-Treatment) 11/2016